Arylethanolamines derived from salicylamide with alpha- and beta-adrenoceptor blocking activities. Preparation of labetalol, its enantiomers, and related salicylamides

J Med Chem. 1982 Jun;25(6):670-9. doi: 10.1021/jm00348a013.

Abstract

A series of phenethanolamines (3) based on salicylamide has been prepared and shown to possess beta-adrenergic blocking properties. When the basic nitrogen atom was substituted by some aralkyl groups, the compounds also blocked alpha-adrenoceptors. The 1-methyl-3-phenylpropyl derivative labetalol (34) is antihypertensive in animals and man, and syntheses of its four stereoisomers are described. The enantiomer 90 with the R configuration at both asymmetric centers possessed most of the beta-blocking activity but little alpha-blocking activity. That with the S configuration at the alcoholic carbon and the R configuration on the amino substituent, 89, is predominantly an alpha-adrenoceptor blocking agent.

MeSH terms

  • Adrenergic alpha-Antagonists / chemical synthesis*
  • Adrenergic beta-Antagonists / chemical synthesis*
  • Animals
  • Chemical Phenomena
  • Chemistry
  • Dogs
  • Ethanolamines / chemical synthesis*
  • Ethanolamines / pharmacology
  • Labetalol / chemical synthesis*
  • Muscle, Smooth, Vascular / drug effects
  • Phentolamine / pharmacology
  • Propranolol / pharmacology
  • Salicylamides / chemical synthesis*
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • Adrenergic alpha-Antagonists
  • Adrenergic beta-Antagonists
  • Ethanolamines
  • Salicylamides
  • Propranolol
  • Labetalol
  • Phentolamine